微信关注
China
Total item
Cart Subtotal
￥ 0.00 MAPK
-
TCS JNK 5a
Catalog No. A11969 JNK 抑制剂 IXTCS JNK 5a是JNK2和JNK3的高度选择性抑制剂（对于JNK3，JNK2，JNK1和p38β，pIC50值分别为6.7、6.5，<5.0和<4.8）。 了解更多 -
Vacquinol-1
Catalog No. A15883 -
IQ-1S
Catalog No. A16062 -
Anisomycin
Catalog No. A11271 SAPKs/JNKs activatorAnisomycin是一种吡咯烷类抗生素，用作抑制蛋白质合成的抗真菌抗生素，也是SAPK/JNK的有效激活剂。 了解更多 -
SR 3576
Catalog No. A16020 -
c-JUN peptide
Catalog No. A16045 -
CC-930 (Tanzisertib)
Catalog No. A13564 JNK 抑制剂CC-930在蛋白底物c-Jun的JNK依赖性磷酸化中与ATP动力学竞争，并且对JNK的所有同工型均有效（Ki（JNK1）= 44±3 nM，IC50（JNK1）= 61 nM，Ki（JNK2 ）= 6.2±0.6 nM，IC50（JNK2）= 5 nM，IC50（JNK3）= 5 nM），对MAP激酶ERK1和p38a具有选择性，IC50分别为0.48和3.4μM。 了解更多 -
CEP-1347
Catalog No. A13565 -
CC-401 hydrochloride
Catalog No. A15037 -
JIP-1 (153-163)
Catalog No. A16041 JNK 抑制剂JIP-1 (153-163)是c-Jun N末端激酶（JNK）的肽抑制剂，基于JNK相互作用蛋白1（JIP-1）的153-163残基。以微摩尔范围的亲和力与JNK结合，并最小程度地抑制p38和ERK。 了解更多 -
LY2228820 (Ralimetinib)
Catalog No. A10545 -
VX-745
Catalog No. A10983 -
Asiatic acid
Catalog No. A10092 Anti-inflammatory agentAsiatic acid常用于伤口愈合。亚洲酸具有抗氧化，抗炎和神经保护的特性。积雪草酸衍生物的合成可用作抗癌剂；糖原磷酸化酶抑制剂；保肝剂。 了解更多 -
Talmapimod (SCIO-469)
Catalog No. A12770 -
Losmapimod (GW856553X)
Catalog No. A12526 p38 MAPK 抑制剂Losmapimod，也称为GW856553或GW856553X，是葛兰素史克（GlaxoSmithKline）开发的药物，可作为酶家族的选择性抑制剂，称为p38促分裂原活化蛋白激酶，其作用于p38α和p38β的pKi分别为8.1和7.6 。 了解更多 -
Pamapimod (R-1503)
Catalog No. A13551 -
CMPD-1
Catalog No. A16040 -
TA-02
Catalog No. A13644 -
FR 167653 free base
Catalog No. A21110 p38 MAPK inhibitorFR 167653 free base, an orally active and selective p38 MAPK inhibitor, is a potent suppressor of TNF-α and IL-1β production via specific inhibition of p38 MAPK activity. 了解更多 -
SB 203580 hydrochloride
Catalog No. A21526 p38 MAPK inhibitorSB 203580 hydrochloride (RWJ 64809 hydrochloride) is a widely used p38 MAPK inhibitor. 了解更多 -
MW-150 hydrochloride
Catalog No. A21854 p38α MAPK inhibitorMW-150 hydrochloride (MW01-18-150SRM hydrochloride) is a selective, CNS penetrant, and orally active inhibitor of p38α MAPK with a Ki of 101 nM. 了解更多 -
MW-150 dihydrochloride dihydrate
Catalog No. A21860 p38α MAPK inhibitorMW-150 dihydrochloride dihydrate (MW01-18-150SRM dihydrochloride dihydrate) is a selective, CNS penetrant, and orally active inhibitor of p38α MAPK with a Ki of 101 nM. 了解更多 -
BMS-582949 hydrochloride
Catalog No. A21914 p38α MAPK inhibitorBMS-582949 hydrochloride is an orally active and highly selective p38α MAPK inhibitor, with an IC50 of 13 nM. 了解更多 -
Ralimetinib
Catalog No. A21942 p38 MAPK α/β inhibitorRalimetinib (LY2228820) is a potent and selective, ATP-competitive inhibitor of p38 MAPK α/β, with IC50s of 5.3 and 3.2 nM, respectively. 了解更多 -
p38-α MAPK-IN-1
Catalog No. A21036 MAPK14 inhibitorp38-α MAPK-IN-1 is an inhibitor of MAPK14 (p38-α), with IC50 of 2300 nM in EFC displacement assay, and 5500 nM in HTRF assay. 了解更多 -
MAPK13-IN-1
Catalog No. A21038 MAPK13 (p38??) inhibitorMPAK13-IN-1 is a MAPK13 (p38δ) inhibitor, with an IC50 of 620 nM. 了解更多 -
SB-242235
Catalog No. A13678 -
BMS-582949
Catalog No. A13563 -
Pexmetinib (ARRY-614)
Catalog No. A10895 p38 MAPK 抑制剂Pexmetinib (ARRY-614)是通过双重抑制p38促分裂原活化蛋白激酶（MAPK）和Tie2/Tek受体酪氨酸激酶，其在HEK-293细胞中的IC50分别为4 nM/18 nM。Pexmetinib是一种有效的细胞因子合成抑制剂。 了解更多
FILTER BY:
购物选项
- 分类
- 作用机制
-
- Inhibitor (抑制剂) (167)
- Activator (激活剂) (2)
- 靶点
-
- Abl (1)
- Aurora A (1)
- Aurora B (2)
- Aurora C (1)
- B-Raf (22)
- BRK (1)
- C-Raf (Raf-1) (17)
- CDK2 (1)
- EphB4 (1)
- ERK5 (1)
- FGFR3 (1)
- GSK-3β (1)
- JAK3 (1)
- Kit (2)
- Lck (2)
- MEK1 (25)
- MEK2 (19)
- MEK5 (2)
- Mnk1 (1)
- Mnk2 (1)
- p38α (1)
- PDGFRα (1)
- PDGFRβ (5)
- Raf (3)
- RET (3)
- RKIP (1)
- Src (1)
- SRMS (1)
- VEGFR1 (FLT1) (2)
- VEGFR2 (FLK1) (4)
- VEGFR3 (FLT4) (2)
联系我们
United StatesAdooq Bioscience
Toll Free: (866) 930-6790
Fax: +1-323-606-8156
Email: sales@adooq.com
Not your Region? View all Distributors
ADOOQ 产品质量保证
We promise all products to perform as described.